Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Neuronetics Inc/
Recent news which mentions Neuronetics Inc/
Lab Notes: CHOP gets $10M research gift; Vallon seeks greater shareholder support for merger
April 07, 2023
Tickers
INNO
Tags
Nick Gilbert
Children's Hospital Of Philadelphia
Vallon Pharmaceuticals Inc/
From
Business Journals
Lab Notes: Neuronetics resolves lawsuit; Harmony CEO departs; Ocugen issues results of Covaxin study
January 13, 2023
Tickers
INNO
Tags
Health Care
Christopher von Jako
David Prohaska
From
Business Journals
Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'
July 22, 2022
Tickers
INNO
Tags
Arbutus Biopharma Corporation
Inno
Nabriva Therapeutics plc Ireland
From
Business Journals
Neuronetics gets FDA approval for wider use of its NeuroStar treatment system
May 12, 2022
Tags
Keith J/ Sullivan
Neuronetics Inc/
Insurance
From
Business Journals
Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
May 06, 2022
Tickers
INNO
Tags
Scott Sims
Health Care
Patricia Torr
From
Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
April 15, 2022
Tickers
INNO
Tags
Ben Franklin Technology Partners
Context Therapeutics
Health Care
From
Business Journals
Lab Notes: Imvax presents new data on lead drug candidate; Neuronetics forms new partnership
November 12, 2021
Tickers
INNO
Tags
Insurance
Keith J/ Sullivan
Neuronetics Inc/
From
Business Journals
Lab Notes: NFlection names new CEO; Immunocore enters into cancer drug partnership
October 22, 2021
Tickers
INNO
Tags
Libbie Mansell
Health Care
Nflection Therapeutics
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.